Endometrial Changes in Surgical Specimens of Perimenopausal Patients Treated With Ulipristal Acetate for Uterine Leiomyomas

Nogales FF, Francisco F. Nogales, Crespo-Lora V, Vicente Crespo‐Lora, Vicente Crespo-Lora, Cruz-Viruel N, Nelly Cruz-Viruel, Nelly Cruz‐Viruel, Chamorro-Santos C, C.E. Chamorro-Santos, Clara Chamorro-Santos, Christine Bergeron, Bergeron C
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists · 2017 · vol. 37(6) , pp. 575–580 · doi:10.1097/pgp.0000000000000450 · PMID:28914672 · W2755197954
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study examined hysterectomy specimens from 100 women treated with ulipristal acetate for uterine leiomyomas, finding progesterone receptor modulators-associated endometrial changes in 59% of cases, predominantly focally and within 4 weeks of treatment discontinuation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ulipristal acetate (UPA) is used to treat leiomyomas, and its effect on the endometrium has been studied in biopsy material. Reversible histologic modifications were found, named progesterone receptor modulators-associated endometrial changes (PAEC). However, hysterectomies from patients treated with UPA have not been analyzed. For the first time, we examined surgical specimens from 100 leiomyoma-treated patients for UPA-related endometrial changes. We analyzed the distribution of lesions, involution after treatment, and the relationship between type and extent of lesions and dosage. Clinically, 72 patients were treated with 1 cycle of UPA; 23 patients with 2 cycles, and 5 with 3 cycles. A total of 66 patients underwent surgery in the first 4 wk after treatment, 24 were operated between 5 and 12 wk after discontinuation of UPA, and 10 after more than 12 wk after the last cycle, up to a maximum of 32 wk. Histologically normal endometria were found in 41 cases and PAEC in 59 cases. PAEC consisted of irregular, cystic glands showing a flattened secretory-like epithelium with vacuolation, coexisting mitoses and apoptosis, and were found focally within cyclic endometria in 51 cases. Only in 8 cases did diffuse PAEC involve the whole endometrium, transforming it into a thick spongy cushion. PAEC also occurred in adenomyosis. There was no relationship between dosage and type and extent of lesions. Diffuse PAEC, which usually presents differential diagnoses with hyperplasia, occurred in only 8 cases, being only present during the first 4 wk after discontinuation of treatment and was independent of the number of cycles administered.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Endometrium Leiomyoma Norpregnadienes Uterine Neoplasms Adult Endometrium Endometrium Endometrium Female Humans Leiomyoma Leiomyoma Leiomyoma Middle Aged Norpregnadienes Norpregnadienes Perimenopause Uterine Neoplasms Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Cited by (5)

Source provenance

europepmc
last seen: 2026-09-21T06:08:07.822426+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:13.663096+00:00
unpaywall
last seen: 2026-09-22T06:12:16.469521+00:00
License: CC0 · commercial use OK